Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-8-20
pubmed:abstractText
The study objective was to assess the cardiac expression of interleukin-6 (IL6) and its receptor (IL6R) in advanced heart failure.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1388-9842
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
415-21
pubmed:dateRevised
2011-6-8
pubmed:meshHeading
pubmed-meshheading:11511426-Adult, pubmed-meshheading:11511426-Biological Markers, pubmed-meshheading:11511426-Biopsy, Needle, pubmed-meshheading:11511426-Blotting, Northern, pubmed-meshheading:11511426-Cardiomyopathy, Dilated, pubmed-meshheading:11511426-Culture Techniques, pubmed-meshheading:11511426-Female, pubmed-meshheading:11511426-Heart Transplantation, pubmed-meshheading:11511426-Heart Ventricles, pubmed-meshheading:11511426-Humans, pubmed-meshheading:11511426-In Situ Hybridization, pubmed-meshheading:11511426-Interleukin-6, pubmed-meshheading:11511426-Linear Models, pubmed-meshheading:11511426-Male, pubmed-meshheading:11511426-Middle Aged, pubmed-meshheading:11511426-Probability, pubmed-meshheading:11511426-Prognosis, pubmed-meshheading:11511426-RNA, Messenger, pubmed-meshheading:11511426-Receptors, Interleukin-6, pubmed-meshheading:11511426-Reference Values, pubmed-meshheading:11511426-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:11511426-Sensitivity and Specificity, pubmed-meshheading:11511426-Severity of Illness Index, pubmed-meshheading:11511426-Statistics, Nonparametric
pubmed:year
2001
pubmed:articleTitle
Activation of the cardiac interleukin-6 system in advanced heart failure.
pubmed:affiliation
Department of Cardiothoracic Surgery, University of Muenster, Albert-Schweitzer-Str. 33, D-48129 Muenster, Germany. plenz@uni-muenster.de
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Controlled Clinical Trial, Research Support, Non-U.S. Gov't